These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30024036)

  • 1. The effect of dutasteride on microscopic and macroscopic changes of testosterone replacement treatment on prostate tissue.
    Diri MA; Diri B; Yildiz L; Büyükalpelli R
    Andrologia; 2018 Dec; 50(10):e13110. PubMed ID: 30024036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction.
    Shigehara K; Miyagi T; Nakashima T; Izumi K; Kitagawa Y; Mizokami A; Koh E; Shimamura M; Namiki M
    Aging Male; 2016 Jun; 19(2):128-33. PubMed ID: 26890877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.
    Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM
    J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
    Kacker R; Harisaran V; Given L; Miner M; Rittmaster R; Morgentaler A
    Andrologia; 2015 Mar; 47(2):148-52. PubMed ID: 24499051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dutasteride on serum free-testosterone and clinical significance of testosterone changes.
    Enatsu N; Miyake H; Haraguchi T; Chiba K; Fujisawa M
    Andrologia; 2016 Dec; 48(10):1195-1201. PubMed ID: 26952737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content.
    Shibata Y; Arai S; Miyazawa Y; Shuto T; Nomura M; Sekine Y; Koike H; Matsui H; Ito K; Suzuki K
    Prostate; 2017 May; 77(6):672-680. PubMed ID: 28145028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dutasteride-mediated morphological changes in the genitourinary tract associated with altered expression patterns of the androgen and estrogen receptors in male rats.
    Enatsu N; Chiba K; Sumii K; Fukuda T; Okada K; Matsushita K; Fujisawa M
    Andrology; 2017 Mar; 5(2):347-353. PubMed ID: 27813338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
    Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
    Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dutasteride treatment on serum hormone levels and aging male symptoms in patients with benign prostatic enlargement.
    Maeda T; Kikuchi E; Hasegawa M; Homma K; Ando T; Suzuki K; Kaneko G; Mizuno R; Miyajima A; Oya M
    Int J Urol; 2018 Jan; 25(1):70-74. PubMed ID: 28975673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model.
    Da Silva MHA; Costa WS; B Sampaio FJ; De Souza DB
    Asian J Androl; 2018; 20(5):505-510. PubMed ID: 29893293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer.
    Shao TC; Li H; Ittmann M; Cunningham GR
    J Urol; 2007 Oct; 178(4 Pt 1):1521-7. PubMed ID: 17707058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer prevention with 5-alpha reductase inhibitors: concepts and controversies.
    Liss MA; Thompson IM
    Curr Opin Urol; 2018 Jan; 28(1):42-45. PubMed ID: 29095730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
    Wurzel R; Ray P; Major-Walker K; Shannon J; Rittmaster R
    Prostate Cancer Prostatic Dis; 2007; 10(2):149-54. PubMed ID: 17189955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited influence of dutasteride on individual prostate-specific antigen variability in men with clinical benign prostatic hyperplasia.
    Takeshita H; Kawakami S; Kagawa M; Yano A; Okada Y; Morozumi M
    Int J Urol; 2018 Jun; 25(6):633-634. PubMed ID: 29693288
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of dutasteride in a rat model of chemically induced prostatic inflammation-Potential role of estrogen receptor β.
    Mizoguchi S; Mori K; Shin T; Wang Z; DeFranco DB; Yoshimura N; Mimata H
    Prostate; 2020 Dec; 80(16):1413-1420. PubMed ID: 32941694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dutasteride provides chemoprevention].
    Werner F
    Aktuelle Urol; 2006 Sep; 37(5 Suppl):18. PubMed ID: 23646395
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of the 5α-reductase inhibitor dutasteride on rat prostate α1A-adrenergic receptor and its mediated contractility.
    Wang D; Zha X; Nagase K; Akino H; Muramatsu I; Ito H; Yokoyama O
    Urology; 2015 Mar; 85(3):704.e9-14. PubMed ID: 25733305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
    Clark RV; Hermann DJ; Cunningham GR; Wilson TH; Morrill BB; Hobbs S
    J Clin Endocrinol Metab; 2004 May; 89(5):2179-84. PubMed ID: 15126539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer vision detects subtle histological effects of dutasteride on benign prostate.
    Sethi A; Sha L; Kumar N; Macias V; Deaton RJ; Gann PH
    BJU Int; 2018 Jul; 122(1):143-151. PubMed ID: 29461667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dutasteride for the treatment of prostate-related conditions.
    Slater S; Dumas C; Bubley G
    Expert Opin Drug Saf; 2012 Mar; 11(2):325-30. PubMed ID: 22316171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.